European Equities Traded in the US as American Depositary Decline Slightly in Tuesday Trading

European equities traded in the US as American depositary receipts were edging lower Tuesday morning, declining 0.14% to 1,308.28 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and internet advertising company Criteo (CRTO), which rose 5% and 4.6% respectively. They were followed by medical device maker EDAP TMS (EDAP) and biopharmaceutical company DBV Technologies (DBVT), which were up 3.4% each.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biopharmaceutical company Grifols (GRFS), which fell 8.1% and 7.1% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and financial services company Banco Santander (SAN), which lost 3.1% and 2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma (VRNA) and Adaptimmune Therapeutics (ADAP), which climbed 7.6% and 5.4% higher respectively. They were followed by biopharmaceutical company Amarin (AMRN) and utility company National Grid (NGG), which increased 3.2% and 0.9% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which tumbled 29.9% and 25.5% respectively. They were followed by insurance firm Prudential (PUK) and biopharmaceutical company Mereo BioPharma Group (MREO), which dropped 2.7% and 0.6% respectively.